Cabaletta Short Long Term Debt Total from 2010 to 2024
| CABA Stock | USD 2.42 0.13 5.68% |
Short and Long Term Debt Total | First Reported 2010-12-31 | Previous Quarter 5 M | Current Value 4.1 M | Quarterly Volatility 277.2 K |
Check Cabaletta Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cabaletta Bio's main balance sheet or income statement drivers, such as Interest Expense of 1.4 M, Selling General Administrative of 10.9 M or Research Development of 58.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0241 or PTB Ratio of 4.13. Cabaletta financial statements analysis is a perfect complement when working with Cabaletta Bio Valuation or Volatility modules.
Cabaletta | Short Long Term Debt Total |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:Check out the analysis of Cabaletta Bio Correlation against competitors. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.16) | Return On Assets (0.31) | Return On Equity (0.48) |
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.